At a glance
ClinicalIndex Comparison RecordN/ACompleted· 144,561 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Precision Analytical Retrospective Data Correlation
In Brief
An observational study for Obesity; Endocrine and Hormone Disturbance. Completed, enrolled 144,561 participants across 1 site.
Detailed Summary
Data from previously analyzed clinical samples tested by Precision Analytical, Inc. will be mined to identify and select samples from patients reporting hormone supplement use. Patient demographics (BMI, for example), different therapies and expected changes in hormone levels will be analyzed and hormone metabolite patterns will be compared. Samples will be deidentified prior to analysis.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsObesity; Endocrine, Hormone Disturbance
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartDec 2019
First PostedMar 2020
Primary CompletionMar 2023
TodayJul 2026
First PostedMar 12, 2020
Enrollment StartDec 15, 2019
Primary CompletionMar 28, 2023
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 6.3 years ago